![Young-Sun Sohn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Young-Sun Sohn
Corporate Officer/Principal chez Catholic University of Korea
Postes actifs de Young-Sun Sohn
Sociétés | Poste | Début | Fin |
---|---|---|---|
Catholic University of Korea | Corporate Officer/Principal | 15/09/2011 | - |
Historique de carrière de Young-Sun Sohn
Anciens postes connus de Young-Sun Sohn
Sociétés | Poste | Début | Fin |
---|---|---|---|
Abxign, Inc.
![]() Abxign, Inc. Pharmaceuticals: MajorHealth Technology Abxign, Inc. was established in January 2008 and is located in Samsung Cancer Research building in Seoul National University. Abxign focused on the discovery and development of antibody therapeutics where by first or best-in-class therapies are introduced in large and growing markets with quality partners. Abxign has accumulated therapeutic antibody development technology and experience for many years and maintains relationships with domestic and foreign pharmaceutical companies specialized for each part of the development of antibody therapy. Based on these Abxign's network and technology, it will release the excellent antibodies in the world pharmaceutical market and extend the human life and contribute to improving the quality of life. | President | 15/09/2011 | 25/07/2013 |
CJ CORPORATION | Directeur Technique/Scientifique/R&D | - | - |
DAEWOONG PHARMACEUTICAL CO., LTD | Corporate Officer/Principal | - | - |
Statistiques
Internationale
Corée du Sud | 5 |
Opérationnelle
Corporate Officer/Principal | 2 |
President | 1 |
Chief Tech/Sci/R&D Officer | 1 |
Sectorielle
Health Technology | 3 |
Consumer Services | 2 |
Consumer Non-Durables | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
DAEWOONG PHARMACEUTICAL CO., LTD | Health Technology |
CJ CORPORATION | Consumer Non-Durables |
Entreprise privées | 1 |
---|---|
Abxign, Inc.
![]() Abxign, Inc. Pharmaceuticals: MajorHealth Technology Abxign, Inc. was established in January 2008 and is located in Samsung Cancer Research building in Seoul National University. Abxign focused on the discovery and development of antibody therapeutics where by first or best-in-class therapies are introduced in large and growing markets with quality partners. Abxign has accumulated therapeutic antibody development technology and experience for many years and maintains relationships with domestic and foreign pharmaceutical companies specialized for each part of the development of antibody therapy. Based on these Abxign's network and technology, it will release the excellent antibodies in the world pharmaceutical market and extend the human life and contribute to improving the quality of life. | Health Technology |
- Bourse
- Insiders
- Young-Sun Sohn
- Expérience